DiagnoCure provides update on operations Apr 1, 2008
Update on PCA3 - Pursuing discussions with Gen-Probe Last week, DiagnoCure and Gen-Probe, the Company's PCA3 development and commercialization partner, participated in the 23rd Annual European Association of Urology (EAU) Congress that was held in Milan, Italy ... DiagnoCure owns worldwide rights to PCA3 and licensed the diagnostic rights to Gen-Probe in 2003 ... Based on the agreement signed in 2003 and amended in 2006, Gen-Probe had until March 31, 2008 to submit their version of a PCA3 test... (Canada Newswire)
New study supports use of PCA3-based test for prostate cancer diagnosis - European commercialization in progress Mar 19, 2008
In December, Gen-Probe, to which DiagnoCure granted worldwide diagnostic rights to PCA3 in 2003, announced that they were increasing their sales and marketing team in the region ... The PCA3 test in now available across the European Union and from five laboratories in the United-States that offer a PCA3-based test using analyst specific reagents manufactured by Gen-Probe ... In 2003, the Company entered into a strategic alliance with Gen-Probe (NASDAQ: GPRO) for the development and... (Canada Newswire)
2 companies compete to sell 'superbug' tests to hospitals Mar 4, 2008
But other companies like Roche, Gen-Probe, Third Wave and Qiagen are expected to enter the market in the coming years. People with MRSA in their nasal passages are not infected themselves. (International Herald Tribune -- Business)
County's life sciences industry bright spot amid economic gloom Feb 20, 2008
Acevedo-Vila also visited Connect, the technology entrepreneurship program, and plans to visit Gen-Probe and Biogen Idec's San Diego offices today. "We're learning from those who have been very successful, and the San Diego area has a success story," Acevedo-Vila said. (North County Times)
Wilsons closing 160 of 260 mall stores Feb 16, 2008
Gen-Probe's fourth-quarter profit rises 19. Gen-Probe, a San Diego-based company that makes diagnostic blood tests, said fourth-quarter profit rose 19 percent on higher sales and a beneficial income tax rate. (San Diego Union-Tribune -- Business)
North County Times offers news staff buyouts Feb 14, 2008
Gen-Probe posts fourth-quarter profit of 19. Gen-Probe, a San Diego-based company that makes diagnostic blood tests, said fourth-quarter profit rose 19 percent on higher sales and a beneficial income tax rate. (San Diego Union-Tribune -- Business)
New Urine Test Detects Prostate Cancer Better Than Other Methods, Study Suggests Feb 5, 2008
The study was funded by the Early Detection Research Network, Department of Defense, the National Institutes of Health, the Prostate Cancer Foundation, and Gen-Probe Incorporated of San Diego. The gene fusion technology has been patented by the University of Michigan and licensed to Gen-Probe Inc, which is also developing the PCA3 screening test ... Chinnaiyan is a paid consultant to Gen-Probe. (Science Daily)
Fast Tech Newcomers Feb 1, 2008
Also new for 2008 are Gen-Probe (nasdaq: - - ), which provides tools to diagnose genetic disease via analysis of DNA and RNA, and FalconStor Software (nasdaq: - - ), which develops backup and archive enterprise software ... Gen-Probe (nasdaq: - - ). (Forbes -- Technology)
Experimental Vaccine Halts Prostate Cancer in Mice Feb 1, 2008
The current test, developed at Michigan and marketed by the biotechnology company Gen-Probe, screens for one molecular marker of prostate cancer. The new test screens for four more key markers. (Health-Finder)
DiagnoCure previews Previstage GCC to key audiences Jan 24, 2008
In 2003, the Company entered into a strategic alliance with Gen-Probe (NASDAQ: GPRO) for the development and commercialization of a second-generation test for PCA3, DiagnoCure's proprietary molecular marker highly specific to prostate cancer. The test is now available through laboratories in the U.S. using PCA3 analyte specific reagents (ASR) from Gen-Probe, and in Europe as the CE-marked PROGENSA(TM) PCA3 in vitro assay. (Canada Newswire)
ExonHit Builds A New Organisation Jan 16, 2008
Previous to Epigenomics, Mr. Douglas was Vice President, Sales and Marketing for Biosite where he was responsible for the launch of the cardiovascular diagnostic, BNP. He also served as Vice President, Marketing for Gen-Probe, was Director of Marketing at Centocor and held sales and marketing positions with Sanofi Diagnostics Pasteur and Abbott Laboratories. Mr. Douglas has experience in cardiovascular, oncology and infectious disease diagnostics. (PR Newswire)
The Cancer That Shouldn't Be Jan 12, 2008
Roche also has an HPV test now under FDA review, and biotechs Third Wave, Gen-Probe (nasdaq: - - ) and SensiGen are developing tests. Merck (nyse: - - )'s heavy marketing of its two-year-old Gardasil HPV vaccine ($1. (Forbes)
Program offers free early-detection HIV test Dec 28, 2007
The Procleix early test, based on technology by Gen-Probe Inc., can eliminate almost all of that margin of error, said Dr. Sheldon Morris, an AIDS researcher and a clinical professor of medicine at UCSD's Antiviral Research Center in Hillcrest. Traditional tests look for antibodies that a person's immune system takes weeks or months to produce in response to an HIV infection. (San Diego Union-Tribune)
Nominate Your Innovative Healthcare Company for a 2008 ABBY Award Dec 21, 2007
2006 BeWell Mobile Technology Inc. Gen-Probe, Inc. Health Hero Network, Inc. Kaiser Permanente Ken Kizer, M.D., Under Secretary for Health, U.S. Dept. of Veterans Affairs (1994 1999) Leadership in Innovation Awardee/Keynoter. 2005 FoxHollow Technologies Care Level Management Refractec Kent Thiry, CEO, DaVita Inc.. (Yahoo News -- Press Releases)
Gen-Probe to Webcast Three Upcoming Presentations Nov 16, 2007
- Annual Analyst Day for Institutional Investors and Financial Analysts on November 29 - - Lazard's Fourth Annual Health Care Conference on November 27 - - 19th Annual Piper Jaffray Health Care Conference on November 28 - SAN DIEGO, Nov. 15 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: ) announced today that the Company will webcast its annual meeting with institutional investors and financial analysts in New York on Thursday, November 29, 2007, at approximately noon Eastern Time.... (PR Newswire)
Yahoo settles China-related suit Nov 14, 2007
3M stops funding Gen-Probe deal. Gen-Probe said that 3M will no longer fund the companies' collaboration to develop molecular tests for the food-testing industry ... Gen-Probe, a San Diego-based company developing products to test blood for disease and harmful organisms, still anticipates receiving a $2 million milestone payment from 3M in the fourth quarter. (San Diego Union-Tribune -- Business)
FCC bans cable TV deals in multi-unit housing Nov 1, 2007
Gen-Probe posts rise in third-quarter income. Gen-Probe Inc., a San Diego-based diagnostics company, reported third-quarter income of $17. (San Diego Union-Tribune -- Business)
Opportunities essential for drawing 'knowledge workers' Oct 31, 2007
MPI's work has led to partnerships with other national companies such as AmeriPath and Gen-Probe to distribute and develop tests. MPI also creates business for local companies, such as Tucson-based Ventana Medical Systems Inc., which supplies MPI with diagnostic equipment used to analyze cancers and personalize medical care for patients. (AZCentral -- News)
Genetic test for prostate cancer Sep 22, 2007
The Progensa test, developed by Gen-Probe, measures the activity of a gene closely linked to prostate cancer - PCA3. PROSTATE CANCER In the UK, about 73 men out of every 1,000 get prostate cancer at some point in their lives 63% of cases are in men aged 70 and over If you have a relative diagnosed with prostate cancer you are at double the risk of getting the disease. (BBC News -- Health)
Gen-Probe to Webcast Presentation at UBS Global Life Sciences Conference Sep 21, 2007
SAN DIEGO, Sept. 20 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: ) announced today that the Company will present at the UBS Global Life Sciences Conference in New York on September 24, 2007 at approximately noon Eastern Time (9:00 a.m. Pacific Time). The presentation is scheduled to be webcast live and may be accessed through a link on the investor information section of Gen-Probe's website at ... About Gen-Probe Gen-Probe Incorporated is a global leader in the development,... (PR Newswire)
HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes Sep 18, 2007
6 Gen-Probe Inc. GPRO 189864140. 9 Varian Medical Systems VAR 288080002. (PR Newswire)
First genetic test for prostate cancer Sep 16, 2007
The new test, called the PCA3, is being marketed by the American company Gen-Probe and will have the backing of leading cancer experts and campaigners. It looks for a gene in men s urine that is produced by prostate cancer cells. (Times Online)
Dispute Between Broadcom and Qualcomm Provides Window Into World of Big IP Fees Sep 8, 2007
R. William Bowen, general counsel for San Diego's Gen-Probe Inc., hired WilmerHale and Lee several years ago to defend them against patent infringement allegations ... Bowen said that in his experience with WilmerHale he didn't try to negotiate any discounts because it was the first time Gen-Probe had hired the firm. (Law.com)
FDA OKs 2nd automated test for West Nile virus Sep 1, 2007
The first fully automated test was developed by San Diego's Gen-Probe Inc. and marketed by Emeryville's Novartis Vaccines and Diagnostics Inc., part of Novartis AG.. Both tests are able to detect the genetic material of the virus itself early in the infection. (Xinhuanet, China)
Gene Fusions Trigger Cancer Growth Aug 3, 2007
The gene fusion technology has been licensed to San Diego-based Gen-Probe Inc., which is working on a screening tool to detect gene fusions in urine ... Funding for the study came from the U.S. Department of Defense, the National Institutes of Health, the Early Detection Research Network, the Prostate Cancer Foundation and Gen-Probe Inc. ... The diagnostic field of use has been licensed to Gen-Probe Inc. Chinnaiyan also has a sponsored research agreement with Gen-Probe; however, GenProbe has had... (Science Daily)
Gen-Probe's profits double in second quarter Aug 3, 2007
Gen-Probe, a San Diego-based diagnostics test maker, doubled its profits during the second quarter on revenue that increased 19 percent, beating Wall Street estimates by 9 cents. For the quarter ended June 30, the company reported income of $27 million, or 50 cents a share, up from $13. (San Diego Union-Tribune -- Business)
Gen-Probe Authorized To Join Digene-Roche Arbitration Proceeding Jul 17, 2007
July 16 /PRNewswire-FirstCall/ -- Digene Corp. (Nasdaq: ) today announced that on July 13, the panel hearing the arbitration proceeding between Digene and Roche granted Gen-Probe, Inc.'s petition to participate as a party. In the proceeding, Digene is seeking a determination that a February 2005 supply and license agreement between Roche and Gen-Probe was an illegal sublicense under a 1990 cross-license agreement, the rights under which are held by Digene and Roche ... Daryl Faulkner, president... (PR Newswire)
Sector Snap: Medical Diagnostics Makers Jul 15, 2007
Shares of molecular diagnostics company Gen-Probe Inc. (nasdaq: - - ) fell 25 cents to $59. 86, and health care products company Covidien Ltd. fell 25 cents to $44. (Forbes)
Group meets to work on improving business ties Jul 11, 2007
With meetings like this, we can set our sights on certain goals to achieve them, said Hank Nordhoff, president of Gen-Probe, who hosted the meeting at his corporate headquarters. Representatives from such entities as Shea Homes, Solar Turbines, Cubic Corp., National University and Amylin Pharmaceuticals attended the meeting. (San Diego Union-Tribune -- Business)
Calbreath: Making sure world is ours Jul 9, 2007
At first glance, the project which will be unveiled at a breakfast meeting tomorrow at the headquarters of the Gen-Probe biotech firm in Mira Mesa sounds like it could be nothing more than an exercise in unvarnished boosterism. But the EDC has had some measurable success with such partnerships. (San Diego Union-Tribune)
Digene buyer gains edge in a hot area of biotech Jun 5, 2007
California's Gen-Probe Inc. and Wisconsin's Third Wave Technologies Inc. also are developing HPV-related screening mechanisms. "They're all vying for the same thing; they want a piece of the market. Companies are working on this because it's a very large potential market opportunity," said Amit Hazan, a biotechnology analyst with CIBC World Markets in New York. (Sunspot.net -- Business)
Digene sold to Dutch biotech Jun 4, 2007
California's Gen-Probe Inc. and Wisconsin's Third Wave Technologies also are developing HPV-related screening mechanisms. A year ago, the FDA approved Gardasil, an HPV vaccine made by Merck & Co. A similar vaccine is under development by GlaxoSmithKline PLC.. (Sunspot.net -- Business)
Manufacturing growth lifts prices May 3, 2007
Gen-Probe to develop med test. San Diego-based Gen-Probe said it would collaborate with 3M to develop nucleic acid tests to detect some dangerous healthcare-associated infections such as methicillin-resistant Staphylococcus aureus ... Terms require Gen-Probe to develop assays, which 3M will largely fund. (San Diego Union-Tribune -- Business)
3M partners with company to develop test for infection May 1, 2007
3M (NYSE: MMM) will also sell the product and share profits with Gen-Probe ... Gen-Probe (Nasdaq: GRPO) and 3M are already co-developing a testing product for the food safety market. (Twin Cities Business Journal, MN)
Flagging a problem Apr 22, 2007
Gen-Probe, a San Diego biotech company, is one of the firms working on a faster test. Dan Kacian, chief scientist at the firm, said researchers have devised a process to detect immediately a molecule found in the enterococcus bacteria. (Boston Globe)
5 TGen spinoffs or affiliates Apr 17, 2007
Other investors include AmeriPath Inc., Affymetrix Inc. and Gen-Probe Inc.. 2. (AZCentral -- Business)
National Hispanic Leaders to Be Honored at Fiesta De Las Estrellas Apr. 12 UCSD, Apr. 06 Apr 7, 2007
Additional sponsors include Bank of America, CDM, College Loan Corporation, Community Health Group, Dudek and Associates, Gen-Probe, The Leyva Family, The Paniagua Family, Port of San Diego, San Diego County Water Authority, San Diego State University, UCSD Chancellor's Office, UCSD School of Medicine, UCSD Student Affairs, Wachovia Education Finance, and Dr. and Mrs. Joseph Watson. Other contributors include Barbara Saltman, Sal and Gail Saucedo, Annabelle ('84) and Robert ('86) Villarreal,... (University of California Newswire, CA)
Gen-Probe to Webcast Presentation at the Lehman Brothers Tenth Annual Global Healthcare Conference Mar 17, 2007
SAN DIEGO, March 16 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: ) announced today that the Company will present at the Lehman Brothers Tenth Annual Global Healthcare Conference in Miami Beach, Florida on March 20, 2007 at 2 p.m. Eastern Time (11 a.m. Pacific Time). The presentation is scheduled to be webcast live and may be accessed through a link on the investor information section of Gen-Probe's website at ... About Gen-Probe Gen-Probe Incorporated is a global leader in the... (PR Newswire)
Digene rival's tests under review by FDA Mar 7, 2007
Multiple businesses and researchers are developing HPV-related screening mechanisms, including California's Gen-Probe Inc. and Wisconsin's Third Wave Technologies. Digene has sued Third Wave for alleged patent infringement. (Sunspot.net -- Business)
FDA Approves Gen-Probe's TIGRIS(R) Instrument to Screen Donated Blood for West Nile Virus Mar 3, 2007
- First Fully Automated Molecular System Enables Blood Centers to Protect Blood Supply With Maximum Efficiency - SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: ) announced today that the U.S. Food and Drug Administration (FDA) has approved the Company's PROCLEIX(R) TIGRIS(R) System, the first fully automated molecular diagnostics instrument, to screen donated blood, organs and tissues for West Nile virus (WNV) using the PROCLEIX WNV Assay. "FDA approval of our... (PR Newswire)
Gen-Probe to Webcast Presentation at the Bear Stearns 9th Annual London Healthcare Conference 2007 Feb 22, 2007
SAN DIEGO, Feb. 21 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: ) announced today that the Company will present at the Bear Stearns 9th Annual London Healthcare Conference 2007 on February 27, 2007 at 9:20 a.m. Greenwich Mean Time (4:20 a.m. Eastern Time). The presentation is scheduled to be webcast live and may be accessed through a link on the investor information section of Gen-Probe's website at ... About Gen-Probe Gen-Probe Incorporated is a global leader in the development,... (PR Newswire)
Nasdaq forecast dims quarter's bright news Feb 14, 2007
Gen-Probe Inc. said fourth-quarter earnings rose to $17 ... Gen-Probe expects 2007 per-share earnings of $1. (San Diego Union-Tribune -- Business)
Rates on short-term T-bills rise Jan 30, 2007
Gen-Probe seeks FDA OK for test. San Diego-based Gen-Probe said that it has applied for Food and Drug Administration approval to run its Procelix Ultrio blood screening test on its Tigris system, which reads the results of the test. (San Diego Union-Tribune -- Business)
'MedImmune v. Genentech': The Supreme Court Upends the Federal Circuit's Declaratory Judgment Jurisprudence Jan 27, 2007
This decision overturned a rule established by the Federal Circuit decision in Gen-Probe Inc. v. Vysis, Inc., 359 F.3d 1376 (Fed ... At the time the Federal Circuit decided Gen-Probe, another declaratory judgment case was pending involving MedImmune Inc. and Genentech Inc. MedImmune had licensed certain intellectual property rights from Genentech, but sued Genentech for a declaration that one of the licensed patents was not infringed by MedImmune's activities and/or was invalid ... When... (Law.com)
